2025 Q3 -tulosraportti
31 päivää sitten48 min
0,95 DKK/osake
Viimeisin osinko
2,72 %Tuotto/v
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
18 138
Myynti
Määrä
9 625
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 850 | - | - | ||
| 2 247 | - | - | ||
| 40 | - | - | ||
| 91 | - | - | ||
| 92 | - | - |
Ylin
35,3VWAP
Alin
34,75VaihtoMäärä
4,8 136 431
VWAP
Ylin
35,3Alin
34,75VaihtoMäärä
4,8 136 431
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 11.2.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 12.11. | |
| 2025 Q2 -tulosraportti | 14.8. | |
| 2025 Q1 -tulosraportti | 14.5. | |
| 2024 Q4 -tulosraportti | 5.2. | |
| 2024 Q3 -tulosraportti | 13.11.2024 |
Datan lähde: Quartr, FactSet
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·27.11.News Today at 7.26 Economist on large Danish stock: It is cheap The Danish pharmaceutical company Lundbeck has withdrawn from the billion-expensive acquisition race for the Irish company Avadel Pharmaceuticals. This is good news for the company's investors, according to investment economist Per Hansen at Nordnet, who also points out that the Lundbeck stock is cheap at the moment. He also offers his suggestion on what the company should do now to secure value for shareholders. "Investors should be pleased that Lundbeck is laying down its arms. It shows that they are not desperate to buy more at any price, and perhaps/hopefully also that they have other and perhaps smaller candidates in their sights," writes Per Hansen in a comment and continues: "Lundbeck has strong sales momentum, and the coming quarters will also be strong. The valuation is low." The Lundbeck stock is currently trading at a P/E multiple – which shows how much investors pay for a share of a company's profit and is used to assess whether a stock is expensive or cheap – of 7.6. This means that as a shareholder in Lundbeck, based on the current share price, you pay 7.6 kr. for one krone of profit in the company. In comparison, the Danish C25 index trades at a P/E multiple of 15, while global stocks trade at a P/E multiple of 22. The Lundbeck stock has seen large fluctuations this year, and is currently 'only' up by almost 5 pct. Per Hansen believes that the company should consider whether it is in the investors' interest that the money being earned right now is not only used for potential acquisitions: "If they wanted to do something for investors, they should think both in relation to acquisitions, but also share buybacks to support shareholder value. There should be room for both in the coming quarters," writes the economist in a comment. Analysts currently expect Lundbeck to achieve a revenue of 24.5 billion kr. and a profit before tax of just under 6 billion kr. In 2024, revenue was 22 billion kr. and the result before tax was 6.8 billion kr. according to Bloomberg.
·26.11.So they gave up the bidding war. I'm honestly glad about that. I think it was a big mouthful. And guaranteed too expensive when they fight over it.·27.11.Completely agree, I'm also really glad that the acquisition didn't happen. In fact, the stock should rise on the good news.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q3 -tulosraportti
31 päivää sitten48 min
0,95 DKK/osake
Viimeisin osinko
2,72 %Tuotto/v
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·27.11.News Today at 7.26 Economist on large Danish stock: It is cheap The Danish pharmaceutical company Lundbeck has withdrawn from the billion-expensive acquisition race for the Irish company Avadel Pharmaceuticals. This is good news for the company's investors, according to investment economist Per Hansen at Nordnet, who also points out that the Lundbeck stock is cheap at the moment. He also offers his suggestion on what the company should do now to secure value for shareholders. "Investors should be pleased that Lundbeck is laying down its arms. It shows that they are not desperate to buy more at any price, and perhaps/hopefully also that they have other and perhaps smaller candidates in their sights," writes Per Hansen in a comment and continues: "Lundbeck has strong sales momentum, and the coming quarters will also be strong. The valuation is low." The Lundbeck stock is currently trading at a P/E multiple – which shows how much investors pay for a share of a company's profit and is used to assess whether a stock is expensive or cheap – of 7.6. This means that as a shareholder in Lundbeck, based on the current share price, you pay 7.6 kr. for one krone of profit in the company. In comparison, the Danish C25 index trades at a P/E multiple of 15, while global stocks trade at a P/E multiple of 22. The Lundbeck stock has seen large fluctuations this year, and is currently 'only' up by almost 5 pct. Per Hansen believes that the company should consider whether it is in the investors' interest that the money being earned right now is not only used for potential acquisitions: "If they wanted to do something for investors, they should think both in relation to acquisitions, but also share buybacks to support shareholder value. There should be room for both in the coming quarters," writes the economist in a comment. Analysts currently expect Lundbeck to achieve a revenue of 24.5 billion kr. and a profit before tax of just under 6 billion kr. In 2024, revenue was 22 billion kr. and the result before tax was 6.8 billion kr. according to Bloomberg.
- ·26.11.So they gave up the bidding war. I'm honestly glad about that. I think it was a big mouthful. And guaranteed too expensive when they fight over it.·27.11.Completely agree, I'm also really glad that the acquisition didn't happen. In fact, the stock should rise on the good news.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
18 138
Myynti
Määrä
9 625
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 850 | - | - | ||
| 2 247 | - | - | ||
| 40 | - | - | ||
| 91 | - | - | ||
| 92 | - | - |
Ylin
35,3VWAP
Alin
34,75VaihtoMäärä
4,8 136 431
VWAP
Ylin
35,3Alin
34,75VaihtoMäärä
4,8 136 431
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 11.2.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 12.11. | |
| 2025 Q2 -tulosraportti | 14.8. | |
| 2025 Q1 -tulosraportti | 14.5. | |
| 2024 Q4 -tulosraportti | 5.2. | |
| 2024 Q3 -tulosraportti | 13.11.2024 |
Datan lähde: Quartr, FactSet
2025 Q3 -tulosraportti
31 päivää sitten48 min
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 11.2.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 12.11. | |
| 2025 Q2 -tulosraportti | 14.8. | |
| 2025 Q1 -tulosraportti | 14.5. | |
| 2024 Q4 -tulosraportti | 5.2. | |
| 2024 Q3 -tulosraportti | 13.11.2024 |
Datan lähde: Quartr, FactSet
0,95 DKK/osake
Viimeisin osinko
2,72 %Tuotto/v
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·27.11.News Today at 7.26 Economist on large Danish stock: It is cheap The Danish pharmaceutical company Lundbeck has withdrawn from the billion-expensive acquisition race for the Irish company Avadel Pharmaceuticals. This is good news for the company's investors, according to investment economist Per Hansen at Nordnet, who also points out that the Lundbeck stock is cheap at the moment. He also offers his suggestion on what the company should do now to secure value for shareholders. "Investors should be pleased that Lundbeck is laying down its arms. It shows that they are not desperate to buy more at any price, and perhaps/hopefully also that they have other and perhaps smaller candidates in their sights," writes Per Hansen in a comment and continues: "Lundbeck has strong sales momentum, and the coming quarters will also be strong. The valuation is low." The Lundbeck stock is currently trading at a P/E multiple – which shows how much investors pay for a share of a company's profit and is used to assess whether a stock is expensive or cheap – of 7.6. This means that as a shareholder in Lundbeck, based on the current share price, you pay 7.6 kr. for one krone of profit in the company. In comparison, the Danish C25 index trades at a P/E multiple of 15, while global stocks trade at a P/E multiple of 22. The Lundbeck stock has seen large fluctuations this year, and is currently 'only' up by almost 5 pct. Per Hansen believes that the company should consider whether it is in the investors' interest that the money being earned right now is not only used for potential acquisitions: "If they wanted to do something for investors, they should think both in relation to acquisitions, but also share buybacks to support shareholder value. There should be room for both in the coming quarters," writes the economist in a comment. Analysts currently expect Lundbeck to achieve a revenue of 24.5 billion kr. and a profit before tax of just under 6 billion kr. In 2024, revenue was 22 billion kr. and the result before tax was 6.8 billion kr. according to Bloomberg.
- ·26.11.So they gave up the bidding war. I'm honestly glad about that. I think it was a big mouthful. And guaranteed too expensive when they fight over it.·27.11.Completely agree, I'm also really glad that the acquisition didn't happen. In fact, the stock should rise on the good news.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
18 138
Myynti
Määrä
9 625
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 850 | - | - | ||
| 2 247 | - | - | ||
| 40 | - | - | ||
| 91 | - | - | ||
| 92 | - | - |
Ylin
35,3VWAP
Alin
34,75VaihtoMäärä
4,8 136 431
VWAP
Ylin
35,3Alin
34,75VaihtoMäärä
4,8 136 431
Välittäjätilasto
Dataa ei löytynyt